Literature DB >> 19633698

Observation of the density and size of cells in hippocampus and vascular lesion in thalamus of GFAP-apoE transgenic mice.

Ke-Feng Tang1, Li Cai, Jiang-Ning Zhou.   

Abstract

OBJECTIVE: Apolipoprotein E (apoE) is associated with increased risk of age-related diseases, such as Alzheimer's disease (AD) and cerebrovascular disease (CVD). The present study aims to investigate the age-related general morphological changes of the brain in GFAP-apoE transgenic mice, especially the alterations in number and size of hippocampal pyramidal cells and the microvascular lesions in the thalamus.
METHODS: Nine female apoE4/4 mice were divided into 3 groups (n=3 in each group): 3-4 months (young group), 9-10 months (middle-aged group) and 20-21 months (old group). Age-matched apoE3/3 mice were employed as control group (n=3 in each group). The paraffin sections of brain tissue were stained by 2 conventional staining methods, thionin staining and hematoxylin-esion(HE) staining, the former of which was to observe the hippocampal cells, while the latter was used to examine the brain microvasculature.
RESULTS: There was no apparent difference in the cortical layer between apoE3/3 and apoE4/4 mice, neither any significant difference in the number of cells in hippocampal CA1-CA3 subfields between apoE3/3 and apoE4/4 mice at various age points (P>0.05). However, the mean size of pyramidal cells in CA1 subfield in apoE3/3 and apoE4/4 mice decreased as mice were getting older (P<0.001). At the age of 20-21 months, this cellular atrophy in apoE4/4 mice was more severe than that in old apoE3/3 mice (P<0.05). Furthermore, microvascular lesion in the thalamus was detected in all the 3 old apoE4/4 mice, at varying degrees (5.24%, 1.41% and 3.97%, respectively), while only one apoE3/3 mouse exhibited microvascular lesion in the thalamus, at a low level (0.85%).
CONCLUSION: The current study suggests that the cell size in hippocampal CA1 subfield decreases with aging, irrespective of apoE genotype. Cellular atrophy in CA1 subfield and the microvascular lesion in the thalamus are both more severe in old apoE4/4 mice as compared with those in age-matched apoE3/3 mice. Doubts still exist on whether the decreased cell size in hippocampal CA1 subfield in old apoE4/4 mice is associated with dysfunction in learning and memory and whether the microvascular lesions indicate a higher risk of stroke in human apoE4 allele mice. To clarify these issues, further investigations are needed.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19633698      PMCID: PMC5552552          DOI: 10.1007/s12264-009-0324-6

Source DB:  PubMed          Journal:  Neurosci Bull        ISSN: 1995-8218            Impact factor:   5.203


  42 in total

Review 1.  Apolipoprotein E: from atherosclerosis to Alzheimer's disease and beyond.

Authors:  R W Mahley; Y Huang
Journal:  Curr Opin Lipidol       Date:  1999-06       Impact factor: 4.776

2.  Apolipoprotein E-deficient mice have increased susceptibility to focal cerebral ischemia.

Authors:  D T Laskowitz; H Sheng; R D Bart; K A Joyner; A D Roses; D S Warner
Journal:  J Cereb Blood Flow Metab       Date:  1997-07       Impact factor: 6.200

3.  Expression of human apolipoprotein E4 in neurons causes hyperphosphorylation of protein tau in the brains of transgenic mice.

Authors:  I Tesseur; J Van Dorpe; K Spittaels; C Van den Haute; D Moechars; F Van Leuven
Journal:  Am J Pathol       Date:  2000-03       Impact factor: 4.307

4.  Preliminary report of a genetic basis for cognitive decline after cardiac operations. The Neurologic Outcome Research Group of the Duke Heart Center.

Authors:  B E Tardiff; M F Newman; A M Saunders; W J Strittmatter; J A Blumenthal; W D White; N D Croughwell; R D Davis; A D Roses; J G Reves
Journal:  Ann Thorac Surg       Date:  1997-09       Impact factor: 4.330

Review 5.  Cerebral microvascular pathology in aging and Alzheimer's disease.

Authors:  E Farkas; P G Luiten
Journal:  Prog Neurobiol       Date:  2001-08       Impact factor: 11.685

6.  ApoE genotype and survival from intracerebral haemorrhage.

Authors:  M J Alberts; C Graffagnino; C McClenny; D DeLong; W Strittmatter; A M Saunders; A D Roses
Journal:  Lancet       Date:  1995-08-26       Impact factor: 79.321

7.  Human E apoprotein heterogeneity. Cysteine-arginine interchanges in the amino acid sequence of the apo-E isoforms.

Authors:  K H Weisgraber; S C Rall; R W Mahley
Journal:  J Biol Chem       Date:  1981-09-10       Impact factor: 5.157

8.  Capillary changes in hippocampal CA1 and CA3 areas of the aging rhesus monkey.

Authors:  J I Keuker; P G Luiten; E Fuchs
Journal:  Acta Neuropathol       Date:  2000-12       Impact factor: 17.088

9.  Incidence of dementia, Alzheimer's disease, and vascular dementia in Italy. The ILSA Study.

Authors:  Antonio Di Carlo; Marzia Baldereschi; Luigi Amaducci; Vito Lepore; Laura Bracco; Stefania Maggi; Salvatore Bonaiuto; Egle Perissinotto; Guglielmo Scarlato; Gino Farchi; Domenico Inzitari
Journal:  J Am Geriatr Soc       Date:  2002-01       Impact factor: 5.562

10.  Primary prevention of acute coronary events with lovastatin in men and women with average cholesterol levels: results of AFCAPS/TexCAPS. Air Force/Texas Coronary Atherosclerosis Prevention Study.

Authors:  J R Downs; M Clearfield; S Weis; E Whitney; D R Shapiro; P A Beere; A Langendorfer; E A Stein; W Kruyer; A M Gotto
Journal:  JAMA       Date:  1998-05-27       Impact factor: 56.272

View more
  4 in total

Review 1.  From chronic cerebral hypoperfusion to Alzheimer-like brain pathology and neurodegeneration.

Authors:  Yang Zhao; Cheng-Xin Gong
Journal:  Cell Mol Neurobiol       Date:  2014-10-29       Impact factor: 5.046

Review 2.  Alzheimer's disease pathology in APOE transgenic mouse models: The Who, What, When, Where, Why, and How.

Authors:  Cutler T Lewandowski; Juan Maldonado Weng; Mary Jo LaDu
Journal:  Neurobiol Dis       Date:  2020-02-20       Impact factor: 5.996

3.  Introducing Human APOE into Aβ Transgenic Mouse Models.

Authors:  Leon M Tai; Katherine L Youmans; Lisa Jungbauer; Chunjiang Yu; Mary Jo Ladu
Journal:  Int J Alzheimers Dis       Date:  2011-10-19

4.  Association of Hippocampal Subfield Volumes with Amyloid-Beta Deposition in Alzheimer's Disease.

Authors:  Min Seok Baek; Narae Lee; Jin Woo Kim; Jin Yong Hong
Journal:  J Clin Med       Date:  2022-03-10       Impact factor: 4.241

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.